IRIS Accounts Production v24.1.0.578 11278491 director 1.4.22 30.9.23 30.9.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112784912022-03-31112784912023-09-30112784912022-04-012023-09-30112784912021-03-31112784912021-04-012022-03-31112784912022-03-3111278491ns15:EnglandWales2022-04-012023-09-3011278491ns14:PoundSterling2022-04-012023-09-3011278491ns10:Director12022-04-012023-09-3011278491ns10:PrivateLimitedCompanyLtd2022-04-012023-09-3011278491ns10:SmallEntities2022-04-012023-09-3011278491ns10:AuditExempt-NoAccountantsReport2022-04-012023-09-3011278491ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-09-3011278491ns10:SmallCompaniesRegimeForAccounts2022-04-012023-09-3011278491ns10:FullAccounts2022-04-012023-09-3011278491ns10:RegisteredOffice2022-04-012023-09-3011278491ns5:CurrentFinancialInstruments2023-09-3011278491ns5:CurrentFinancialInstruments2022-03-3111278491ns5:Non-currentFinancialInstruments2023-09-3011278491ns5:Non-currentFinancialInstruments2022-03-3111278491ns5:ShareCapital2023-09-3011278491ns5:ShareCapital2022-03-3111278491ns5:RetainedEarningsAccumulatedLosses2023-09-3011278491ns5:RetainedEarningsAccumulatedLosses2022-03-3111278491ns5:PlantMachinery2022-03-3111278491ns5:PlantMachinery2022-04-012023-09-3011278491ns5:PlantMachinery2023-09-3011278491ns5:PlantMachinery2022-03-3111278491ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3011278491ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31112784911ns10:Director12022-03-31112784911ns10:Director12021-03-31112784911ns10:Director12022-04-012023-09-30112784911ns10:Director12021-04-012022-03-31112784911ns10:Director12023-09-30112784911ns10:Director12022-03-31
REGISTERED NUMBER: 11278491 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023

FOR

ANGEL ROSE MEDICAL AESTHETICS LIMITED

ANGEL ROSE MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 11278491)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ANGEL ROSE MEDICAL AESTHETICS LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023







DIRECTOR: Mrs K Mitchell





REGISTERED OFFICE: 6 Beck Way
East Ardsley
Wakefield
West Yorkshire
WF3 2NA





REGISTERED NUMBER: 11278491 (England and Wales)





ACCOUNTANTS: Temporal Lennon & Company Limited
Chartered Accountants
Suite 1
1 The Crescent
Adel
Leeds
West Yorkshire
LS16 6AA

ANGEL ROSE MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 11278491)

BALANCE SHEET
30 SEPTEMBER 2023

30.9.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 963

CURRENT ASSETS
Stocks - 2,800
Debtors 5 3,515 13,794
Cash at bank 3 19
3,518 16,613
CREDITORS
Amounts falling due within one year 6 6,501 21,534
NET CURRENT LIABILITIES (2,983 ) (4,921 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(2,983

)

(3,958

)

CREDITORS
Amounts falling due after more than one
year

7

-

14,667
NET LIABILITIES (2,983 ) (18,625 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (3,083 ) (18,725 )
SHAREHOLDERS' FUNDS (2,983 ) (18,625 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 March 2024 and were signed by:





Mrs K Mitchell - Director


ANGEL ROSE MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 11278491)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023

1. STATUTORY INFORMATION

Angel Rose Medical Aesthetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Accounting period end
The company extended its reporting period end from 31 March 2023 to 30 September 2023 being the date the company ceased trading. As such the period covered by the financial statements is for eighteen months and therefore comparative values are not entirely comparable.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2022 - 1 ) .

ANGEL ROSE MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 11278491)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 1,658
Disposals (1,658 )
At 30 September 2023 -
DEPRECIATION
At 1 April 2022 695
Charge for period 361
Eliminated on disposal (1,056 )
At 30 September 2023 -
NET BOOK VALUE
At 30 September 2023 -
At 31 March 2022 963

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 31.3.22
£    £   
Trade debtors 50 -
Other debtors 3,465 13,794
3,515 13,794

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 31.3.22
£    £   
Bank loans and overdrafts - 4,000
Trade creditors - 3,385
Taxation and social security 372 711
Other creditors 6,129 13,438
6,501 21,534

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
30.9.23 31.3.22
£    £   
Bank loans - 14,667

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 30 September 2023 and the year ended 31 March 2022:

30.9.23 31.3.22
£    £   
Mrs K Mitchell
Balance outstanding at start of period 10,663 6,894
Amounts advanced 17,502 10,329
Amounts repaid (32,263 ) (6,560 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period (4,098 ) 10,663

The loan account is interest free and repayable on demand.

ANGEL ROSE MEDICAL AESTHETICS LIMITED (REGISTERED NUMBER: 11278491)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2022 TO 30 SEPTEMBER 2023

9. ULTIMATE CONTROLLING PARTY

The controlling party is Mrs K Mitchell.